Biased agonism at adenosine receptors

Area of Science:

• Pharmacology
• Molecular Biology
• Drug Discovery

Background:

• Adenosine receptors (A1R, A2AR, A2BR, A3R) are key regulators of human physiology and disease.
• Existing adenosine receptor ligands often face clinical trial failures due to limited efficacy or severe side effects.

Purpose of the Study:

• To review advancements in biased agonism for adenosine receptors.
• To explore harnessing biased agonism for therapeutic benefit.

Main Methods:

• Review of recent scientific literature on adenosine receptor biased agonism.
• Analysis of structure-function relationships underpinning biased agonism.

Main Results:

• Biased agonism allows for selective activation of therapeutic signaling pathways.
• This approach can mitigate on-target undesired effects associated with traditional ligands.

Conclusions:

• Biased agonism represents a promising strategy to overcome clinical translation barriers for adenosine receptor-targeting drugs.
• Further research into structure-function relationships will enable the development of safer and more effective therapeutics.